REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 31 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $109,000 | -16.8% | 180,000 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $131,000 | +4.0% | 180,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $126,000 | -13.7% | 180,000 | 0.0% | 0.00% | -25.0% |
| Q3 2014 | $146,000 | -7.0% | 180,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $157,000 | -19.1% | 180,000 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $194,000 | – | 180,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northeast Financial Consultants Inc | 150,000 | $105,000 | 0.06% |
| Benin Management CORP | 83,000 | $58,000 | 0.03% |
| CONDOR CAPITAL MANAGEMENT | 121,324 | $85,000 | 0.02% |
| First Heartland Consultants, Inc. | 30,000 | $21,000 | 0.01% |
| FCG ADVISORS, LLC | 15,000 | $11,000 | 0.01% |
| Advisory Services Network, LLC | 22,000 | $16,000 | 0.01% |
| Virtu KCG Holdings LLC | 346,822 | $243,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,000 | $126,000 | 0.00% |
| Moors & Cabot, Inc. | 18,000 | $12,000 | 0.00% |
| Corbenic Partners LLC | 1,600 | $1,000 | 0.00% |